Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9390008rdf:typepubmed:Citationlld:pubmed
pubmed-article:9390008lifeskim:mentionsumls-concept:C0001655lld:lifeskim
pubmed-article:9390008lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9390008lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:9390008lifeskim:mentionsumls-concept:C0002302lld:lifeskim
pubmed-article:9390008lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:9390008lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:9390008pubmed:issue1lld:pubmed
pubmed-article:9390008pubmed:dateCreated1997-12-17lld:pubmed
pubmed-article:9390008pubmed:abstractTextACTH(1-39), and several shorter N- and/or C-terminally truncated fragments of ACTH, with and without N-terminal acetylation and/or C-terminal amidation, were tested for binding on a single eukaryotic cell line transiently and independently expressing the melanocortin MC1, MC3, MC4 and MC5 receptors. The results show that none of these MC receptors has specific binding epitopes for the ACTH peptides beyond the amino acid sequence of alpha-MSH, when tested for their ability to compete with 125I-labelled [Nle4,D-Phe7]alpha-MSH and ACTH. The MC3 receptor favours the natural desacetylated N-terminal end of the ACTH peptides, and it has generally more than 10-fold higher affinity for the ACTH peptides than the MC4 receptor. Considering earlier anatomical localisation data, together with the present data, we suggest that the MC3 receptor is the most likely candidate of the MC receptors to mediate the short-loop negative feedback release of corticotrophin-releasing factor (CRF) caused by ACTH/MSH peptides.lld:pubmed
pubmed-article:9390008pubmed:languageenglld:pubmed
pubmed-article:9390008pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:citationSubsetIMlld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9390008pubmed:statusMEDLINElld:pubmed
pubmed-article:9390008pubmed:monthOctlld:pubmed
pubmed-article:9390008pubmed:issn0022-0795lld:pubmed
pubmed-article:9390008pubmed:authorpubmed-author:WikbergJ EJElld:pubmed
pubmed-article:9390008pubmed:authorpubmed-author:LarssonMMlld:pubmed
pubmed-article:9390008pubmed:authorpubmed-author:MucenieceRRlld:pubmed
pubmed-article:9390008pubmed:authorpubmed-author:SchiöthH BHBlld:pubmed
pubmed-article:9390008pubmed:issnTypePrintlld:pubmed
pubmed-article:9390008pubmed:volume155lld:pubmed
pubmed-article:9390008pubmed:ownerNLMlld:pubmed
pubmed-article:9390008pubmed:authorsCompleteYlld:pubmed
pubmed-article:9390008pubmed:pagination73-8lld:pubmed
pubmed-article:9390008pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:meshHeadingpubmed-meshheading:9390008-...lld:pubmed
pubmed-article:9390008pubmed:year1997lld:pubmed
pubmed-article:9390008pubmed:articleTitleThe melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.lld:pubmed
pubmed-article:9390008pubmed:affiliationDepartment of Pharmaceutical Pharmacology, Uppsala University, Sweden.lld:pubmed
pubmed-article:9390008pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9390008pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9390008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9390008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9390008lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9390008lld:pubmed